TrialMedicine2022

Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial.

Qiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.